In summary, these data indicate that ATCs express the dominant pro-phagocytic molecule calreticulin, as well as the “don't eat me” signal CD47 and the immune checkpoint molecules PD-1 and PD-L1, all of which are currently targeted therapeutically in other types of cancer. The gene discussed is PDCD1; the disease is cancer.